Use of erythropoietin_to treat renal failure

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/19 (2006.01) A61L 27/38 (2006.01) A61P 9/00 (2006.01)

Patent

CA 2493598

The invention relates to the use of erythropoietin for stimulation of the physiological mobilisation, proliferation and differentiation of endothelial precursor cells, for stimulation of vasculogenesis, for the treatment of diseases related to a dysfunction of endothelial precursor cells and for the production of pharmaceutical compositions for the treatment of such diseases and pharmaceutical compositions comprising erythropoietin and other agents suitable for stimulation of endothelial precursor cells.

L'invention concerne l'utilisation de l'érythropoïétine pour stimuler la mobilisation physiologique, la prolifération et la différenciation des cellules précurseur endothéliales, stimuler la vasculogenèse, traiter des maladies liées à un dysfonctionnement des cellules précurseur endothéliales, ainsi que pour produire des compositions pharmaceutiques servant à traiter de telles maladies. Cette invention se rapporte en outre à des compositions pharmaceutiques contenant de l'érythropoïétine ainsi que d'autres substances actives appropriées pour stimuler les cellules précurseur endothéliales.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of erythropoietin_to treat renal failure does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of erythropoietin_to treat renal failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of erythropoietin_to treat renal failure will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1987647

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.